2 insider filings
David Raben, new insider at PLRX
Show all 2
- 3New insider at PLRX
- 4Insider filing for PLRX
David Raben
Every EDGAR filing for PLIANT THERAPEUTICS, INC. (PLRX), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 16)
No open-market insider buys in the last 30 days.
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
David Raben, new insider at PLRX
David Raben
Ownership stake disclosure by ADAR1 Capital Management, LLC
ADAR1 Capital Management, LLC, filed by
Ownership stake disclosure by CITADEL ADVISORS LLC (amended)
CITADEL ADVISORS LLC, filed by
Robert Iannone, new insider at PLRX
Robert Iannone, reporting
Thomas A MCCOURT, insider filing for PLRX
Thomas A Mccourt, reporting
Minnie Kuo, insider filing for PLRX
Minnie Kuo, reporting
Ownership stake disclosure by Point72 Asset Management, L.P. (amended)
Point72 Asset Management, L.P., filed by
Ownership stake disclosure by Woodline Partners LP (amended)
Woodline Partners LP, filed by
Ownership stake disclosure by CITADEL ADVISORS LLC
CITADEL ADVISORS LLC, filed by
Ownership stake disclosure by CITADEL ADVISORS LLC
CITADEL ADVISORS LLC, filed by
Keith Lamont Cummings, insider filing for PLRX
Keith Lamont Cummings, reporting
Keith Lamont Cummings, insider filing for PLRX
Keith Lamont Cummings, reporting
Ownership stake disclosure by CITADEL ADVISORS LLC
CITADEL ADVISORS LLC, filed by
Ownership stake disclosure by Stanley Morgan (amended)
Stanley Morgan, filed by
Minnie Kuo, new insider at PLRX
Minnie Kuo, reporting